Inpharma

Ghrelin data reviewed
pp. 2-2(1)

TB back in world spotlight?
pp. 3-3(1)

HRT use discouraged by experts
pp. 3-3(1)

Genetic haplotype markers have been validated for predicting response to statins
pp. 3-3(1)

A proposed provision for US bioterrorism legislation would grant the FDA authority
pp. 3-3(1)

UK NICE issues guidance on bupropion, NRT for smoking cessation . . .
pp. 4-4(1)

Management of schistosomiasis reviewed
pp. 4-4(1)

Pharmacogenomics: the age of `mass customisation'
pp. 5-5(1)

Hepatitis A vaccination in HCV infection cost effective in the US?
pp. 5-5(1)

Denileukin diftitox improves QOL in cutaneous T-cell lymphoma
pp. 5-5(1)

Carvedilol less costly than metoprolol in patients with HF
pp. 6-6(1)

Crohn's disease: better QOL with budesonide
pp. 6-6(1)

Standard adjuvant therapy for colorectal cancer underused in the US?
pp. 6-6(1)

Nitroglycerin beats sphincterotomy for chronic anal fissures
pp. 7-8(2)

Ex vivo c gene therapy successful in X-linked SCID
pp. 9-9(1)

PRIMA-1 restores tumour suppressor activity of mutant p53
pp. 9-9(1)

Bolus administration of GPI-15715 for anaesthesia is comparable to continuous infusion of propofol
pp. 9-9(1)

Benefits of beraprost in pulmonary hypertension
pp. 10-10(1)

Irofulven will no longer be developed for gemcitabine-refractory pancreatic cancer
pp. 10-10(1)

Duloxetine efficacious in major depression
pp. 10-10(1)

Escitalopram has potential in anxiety disorders
pp. 11-12(2)

Erythromycin-resistant group A streptococci in the US
pp. 13-13(1)

Primary PCI superior for acute MI
pp. 13-13(1)

NSAIDs after acute MI in elderly patients
pp. 13-13(1)

NSAIDs reduce risk of prostate cancer?
pp. 14-14(1)

A probiotic containing Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 is useful in preventing urogenital infections
pp. 14-14(1)

Amodiaquine + artesunate: effective antimalarial in African children
pp. 14-14(1)

Statins: early mortality benefit at time of PCI
pp. 14-14(1)

LIPS study validates fluvastatin use after PCI
pp. 15-16(2)

Flecainide + sotalol: new option for SVT therapy in infants
pp. 16-16(1)

Infliximab is an effective treatment for patients with severe spondylarthropathy
pp. 16-16(1)

Stanford V + radiotherapy effective in Hodgkin's disease
pp. 17-17(1)

Short-term antithymocyte globulin in renal transplantation
pp. 17-17(1)

Etanercept is effective in the treatment of chronic graft-versus-host disease
pp. 17-17(1)

Long-term low-dose cyclosporin effective in ITP
pp. 18-18(1)

The benefits of long-term pravastatin therapy observed in the LIPID study continued
pp. 18-18(1)

PCA with remifentanil for pain relief in labour
pp. 18-18(1)

Combination therapy with epirubicin, paclitaxel and cisplatin is effective in patients with advanced cervical cancer
pp. 18-18(1)

Montelukast reduces eosinophilic inflammation in patients with asthma
pp. 19-19(1)

Sirolimus + IL-2 protects against autoimmune diabetes in mice
pp. 19-19(1)

Switch to risperidone for agitated patients with dementia
pp. 19-19(1)

Risperidone concentrations increased by fluoxetine
pp. 19-19(1)

Doxycycline hyclate suppresses neutrophil activity in patients with acute myocardial infarction
pp. 20-20(1)

Postmenopausal calcium supplementation beneficial
pp. 20-20(1)

Among patients receiving olanzapine, heterozygous CYP2D6 *1/*3 and *1/*4 genotypes
pp. 20-20(1)

Adverse event reports following administration of Lyme disease vaccine
pp. 20-20(1)

Rofecoxib labelling updated following VIGOR results
pp. 21-21(1)

Abciximab-specific antibodies induce thrombocytopenia
pp. 21-21(1)

UK market news
pp. 22-22(1)

US market news
pp. 22-22(1)

Clopidogrel [`Plavix'; Sanofi-Synthélabo] has been approved in Canada in an additional indication
pp. 22-22(1)

The transdermal fentanyl patch [`Durotep'; Janssen Pharma, Kyowa Hakko] has been launched in Japan
pp. 22-22(1)

Prednisone associated with mood changes
pp. 22-22(1)

The cream formulation of alprostadil [`Befar'; NexMed] has been launched in Hong Kong
pp. 22-22(1)